Steven Cohen Cerus Corp Put Options Transaction History

Point72 Asset Management, L.P.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2019 Feb 14, 2020	SELL	$3.84 - $4.86 $700,032 - $885,978	-182,300 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$4.86 - $6.05 $885,978 - $1.1 Million	182,300 New	182,300 $940,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $294M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.